wegovy semaglutide for the Treatment of Chronic Weight Management, US Wegovy® Semaglutide 0.25 mg /

[DOI] [PMC free article] [PubMed] [Google Scholar] [19].Rogliani P, Calzetta L, Capuani B, et al

Results The gut microbiota affects locomotion via GLP-1 signaling Animals displayed altered locomotion when their gut microbiome was depleted 13,14,15,16 , suggesting that locomotion is associated with the status of bacterial colonization, specific bacteria, and their metabolites 13,14,15,16

Inject under the skin once a week for 4 weeks

The risk of nausea and vomiting varies across medications

You might start with a 10 mg/mL vial for your 2.5 mg and 5 mg phases, then receive a 20 mg/mL vial when your pharmacy updates its formulation